Overview

Quantum computing is transitioning from pure research to early commercial deployments. IBM, Google, and IonQ are competing on qubit count, error correction, and coherence time. The near-term opportunity is quantum-as-a-service for simulation workloads in drug discovery, materials science, and financial optimization. Fault-tolerant quantum computing with broad applicability remains a decade away, but the infrastructure investments are happening now.

Why It Matters: Quantum computers will break current encryption standards (threatening all digital security) and solve optimization problems classical computers cannot. Governments are investing $50B+ in quantum R&D, creating both direct investment and defense implications.

Key Companies

IONQ
IonQ
Trapped-ion quantum hardware
$8B
RGTI
Rigetti Computing
Superconducting qubits
$2.1B
QBTS
D-Wave Quantum
Quantum annealing
$1.8B
IBM
IBM (IBM Q)
Enterprise quantum cloud
$220B
GOOGL
Alphabet (Google)
Willow chip research
$2.1T
PsiQuantum (pvt)
Photonic quantum
$6B

Growth Drivers

$50B+
Government investment
US, EU, China combined quantum R&D spending through 2030
$50B
Pharma use case
Drug discovery simulation potential value unlocked by quantum advantage
2030
Cryptography threat
Estimated year of harvest now, decrypt later attack becoming viable
+40%/yr
QaaS market growth
Quantum-as-a-service revenue growing rapidly from small base

Key Risks

Risk Factor Detail
Technology timeline uncertainty Fault-tolerant quantum computing timelines consistently pushed back
Extreme valuation premium Pure-play quantum stocks trade on hope, not revenue — 50%+ drawdowns common
Competition from classical AI Classical computing advances reduce near-term quantum advantage window
Talent scarcity Quantum physicists and engineers are extremely scarce globally
Commercialization gap Current quantum hardware has too many errors for most real-world workloads

Related Industries

SemiconductorsCybersecurityPharmaceuticals

Related Themes

Further Research

Combine this theme research with our curated reports and investing tools.